Ignite Creation Date:
2025-12-25 @ 4:13 AM
Ignite Modification Date:
2026-02-24 @ 3:52 PM
Study NCT ID:
NCT02397720
Status:
COMPLETED
Last Update Posted:
2025-06-08
First Post:
2015-03-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Nivolumab and Azacitidine With or Without Ipilimumab in Treating Patients With Refractory/Relapsed or Newly Diagnosed Acute Myeloid Leukemia
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-04-07
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-09
Completion Date Type:
ACTUAL
First Submit Date:
2015-03-19
First Submit QC Date:
None
Study First Post Date:
2015-03-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2024-10-09
Results First Submit QC Date:
None
Results First Post Date:
2024-11-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-28
Last Update Post Date:
2025-06-08
Last Update Post Date Type:
ACTUAL